Tamoxifen’s effects appear to depend on the specific ER isoform, tumor stage, and dosage, acting as a pure ERβ antagonist at certain promoters but exhibiting agonist activity through non-ER mechanisms [104]. Here, ESR1 is linked to neoplasm.